Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Plasma cell disorders

Macrophage Inhibitory Factor-1 (MIF-1) controls the plasticity of multiple myeloma tumor cells

Danielle Joseph, Jason P. Gonsky, Stacy W. Blain

published 01 Nov 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Dietary intake is associated with risk of multiple myeloma and its precursor disease

Marianna Thordardottir, Ebba K. Lindqvist, Sigrun H. Lund, Rene Costello, Debra Burton, Laufey Steingrimsdottir, Neha Korde, Sham Mailankody, Gudny Eiriksdottir, Lenore J. Launer, Vilmundur Gudnason, Tamara B. Harris, Ola Landgren, Johanna E. Torfadottir, Sigurdur Y. Kristinsson

published 01 Nov 2018

Loading metrics information...

Metrics unavailable. Please check back later.

A simple approach for multi-targeted shRNA-mediated inducible knockdowns using Sleeping Beauty vectors

Severin Fink, Laurens Zugelder, Bernhard Roth, Evelyn Brandt, Sylvain Meloche, Zsuzsanna Izsvák, Ralf C. Bargou, Thorsten Stühmer

published 19 Oct 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials

Lucia Lopez-Anglada, Cecilia Cueto-Felgueroso, Laura Rosiñol, Albert Oriol, Ana Isabel Teruel, Ana Lopez de la Guia, Enrique Bengoechea, Luis Palomera, Felipe de Arriba, Jose Mariano Hernandez, Miquel Granell, Francisco Javier Peñalver, Ramon Garcia-Sanz, Juan Besalduch, Yolanda Gonzalez, Rafael Benigno Martinez, Miguel Teodoro Hernandez, Norma C. Gutierrez, Paloma Puerta, Antonio Valeri, Bruno Paiva, Joan Blade, Maria-Victoria Mateos, Jesus San Miguel, Juan Jose Lahuerta, Joaquin Martinez-Lopez, on behalf of the GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Group

published 07 Sep 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up

Hannes Hagström, Anna Andreasson, Axel C. Carlsson, Mats Jerkeman, Mattias Carlsten

published 23 Aug 2018

Loading metrics information...

Metrics unavailable. Please check back later.

The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets

Normann Steiner, Udo Müller, Roman Hajek, Sabina Sevcikova, Bojana Borjan, Karin Jöhrer, Georg Göbel, Andreas Pircher, Eberhard Gunsilius

published 10 Aug 2018

Loading metrics information...

Metrics unavailable. Please check back later.

MALDI-TOF analysis of blood serum proteome can predict the presence of monoclonal gammopathy of undetermined significance

Francisca Barceló, Rosa Gomila, Ivan de Paul, Xavier Gili, Jaume Segura, Albert Pérez-Montaña, Teresa Jimenez-Marco, Antonia Sampol, José Portugal

published 02 Aug 2018

Loading metrics information...

Metrics unavailable. Please check back later.

The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies

Kerrie Faia, Kerry White, Erin Murphy, Jennifer Proctor, Melissa Pink, Nicole Kosmider, Karen McGovern, Jeffery Kutok

published 01 Aug 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients

Ombretta Annibali, Livia Piccioni, Valeria Tomarchio, Erika Circhetta, Chiara Sarlo, Luca Franceschini, Maria Cantonetti, Emanuela Rizzo, Silvia Angeletti, Maria Cristina Tirindelli, Carolina Scagnolari, Maura Statzu, Giuseppe Avvisati, Elisabetta Riva

published 23 Jul 2018

Loading metrics information...

Metrics unavailable. Please check back later.

ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo

Darren L. Lath, Clive H. Buckle, Holly R. Evans, Matthew Fisher, Jenny M. Down, Michelle A. Lawson, Andrew D. Chantry

published 20 Jun 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma

Takashi Yoshida, Masaki Ri, Shiori Kinoshita, Tomoko Narita, Haruhito Totani, Reham Ashour, Asahi Ito, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu, Shinsuke Iida

published 08 May 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Real life management of patients hospitalized with multiple myeloma in France

Charles Dumontet, Sandrine Couray-Targe, Marion Teisseire, Lionel Karlin, Delphine Maucort-Boulch

published 01 May 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Role of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study

Nicolas Belhomme, Stéphane Jouneau, Guillaume Bouzillé, Olivier Decaux, Mathieu Lederlin, Stéphanie Guillot, Antoinette Perlat, Patrick Jégo

published 11 Apr 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Plasma cell disorders

You can change these options by clicking profile then "Alerts and Notifications"